[1] Zhang H, Yang T, Wu M, et al. (2016) Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management. Cancer Lett. 379:198-205.
[2] Spolverato G, Vitale A, Cucchetti A, et al. (2015) Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma? Cancer. 121:3998-4006.
[3] Valle JW, Furuse J, Jitlal M, et al. (2014) Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials. Ann Oncol. 25:391-8.
[4] Valle J, Wasan H, Palmer DH, et al. (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 362:1273-81.
[5] Bourien H, Palard X, Rolland Y, et al. (2019) Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience. Eur J Nucl Med Mol Imaging. 46:669-676.
[6] Al-Adra DP, Gill RS, Axford SJ, et al. (2015) Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis. Eur J Surg Oncol. 41:120-7.
[7] Cucchetti A, Cappelli A, Mosconi C, et al. (2017) Improving patient selection for selective internal radiation therapy of intrahepatic cholangiocarcinoma: A meta regression study. Liver Int. 37:1056-1064.
[8] Nioche C, Orlhac F, Boughdad S, et al. (2018) LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumour Heterogeneity. Cancer Res. 78:4786-4789.
[9] Eisenhauer EA, Therasse P, Bogaerts J, et al. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version1.1). Eur J Cancer 45:228–247.
[10] Ibrahim SM, Mulcahy MF, Lewandowski RJ, et al. (2008) Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study. Cancer 113:2119-2128.
[11] Rafi S, Piduru SM, El-Rayes B, et al. (2013) Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study. Cardiovasc Intervent Radiol 36:440-448.
[12] Mouli S, Memon K, Baker T, et al. (2013) Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Radiol 24:1227-1234.
[13] Saxena A, Bester L, Chua TC, et al. (2010) Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option. Ann Surg Oncol 17:484-491.